Evidence map›Paper›PMID 17297447›Full record

ArticleOncogene2007

HEI10 negatively regulates cell invasion by inhibiting cyclin B/Cdk1 and other promotility proteins.

M K Singh, E Nicolas, W Gherraby, D Dadke, S Lessin, E A Golemis

Open access · greenAbstract read
In one paragraph

Article in Oncogene, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Meiotic Recombination: The Essence of Heredity.Cold Spring Harbor perspectives in biology · 2015
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Knocking down SMC1A inhibits growth and leads to G2/M arrest in human glioma cells.International journal of clinical and experimental pathology · 2013
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

M K SinghInstitute for Cancer Research, Fox Chase Cancer Center, Philadelphia, PA 19111, USA.
E Nicolas
W Gherraby
D Dadke
S Lessin
E A Golemis
Fox Chase Cancer Center · USManipal Academy of Higher Education · IN

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
ROLES OF HEF1 IN CELL DIFFERENTIATION AND SURVIVALR01CA063366 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI GOLEMIS, ERICA A. · 1998 to 2013
$3.9M
NCI NIH HHS CA-06927NCI NIH HHS P30 CA006927NCI NIH HHS R01 CA063366NCI NIH HHS R01 CA63366
6 · The paper itself

Abstract

Human enhancer of invasion, clone 10 (HEI10) (CCNB1IP1) was first described as a RING-finger family ubiquitin ligase that regulates cell cycle by interacting with cyclin B and promoting its degradation. Subsequently, other studies suggested specific upregulation of HEI10 in metastatic melanoma and demonstrated direct interaction between HEI10 and the tumor suppressor Merlin, encoded by the neurofibromatosis 2 gene. These and other results led us to hypothesize that HEI10 also influences the processes of cell migration and metastasis. We here show that cells with depleted HEI10 both migrate more rapidly and invade more effectively than control cells. HEI10 depletion post-transcriptionally increases the expression of a group of promotility regulatory proteins including p130Cas, paxillin, Cdk1 and cyclin B2, but excluding Merlin. Among these, only inhibition of Cdk1/cyclin B activity specifically reversed the motility and invasion of HEI10-depleted cells. Finally, HEI10 is abundantly transcribed in many human tissues, and particularly abundant in some tumor cell lines, suggesting that it may be commonly involved in coordinating cell cycle with cell migration and invasion.

Indexed as

Adaptor Proteins, Signal TransducingAntineoplastic AgentsApoptosisBlotting, WesternCDC2 Protein Kinasecdc42 GTP-Binding ProteinCell Cycle ProteinsCell Line, TumorCell MovementCell ProliferationCisplatinCrk-Associated Substrate ProteinCyclin BFlow CytometryHumansMicroscopy, FluorescenceAdaptor Proteins, Signal TransducingAntineoplastic AgentsBCAR1 protein, humanCCNB1IP1 protein, humanCDC2 Protein Kinasecdc42 GTP-Binding ProteinCell Cycle ProteinsCisplatinCrk-Associated Substrate ProteinCyclin BPaxillinProtein Kinase InhibitorsPurinesRNA, Small InterferingRoscovitineUbiquitin-Protein Ligases

Identifiers

PMID17297447
PMCPMC2597433
OpenAlexW2074493585

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.